Journal article
MRI Deep Learning for Differentiating Glioblastoma, IDH-Wildtype from Central Nervous System Diffuse Large B-cell Lymphoma
Cancer research communications
05/04/2026
DOI: 10.1158/2767-9764.CRC-25-0710
PMID: 42081255
Abstract
Glioblastoma, IDH-wildtype (GBM) and central nervous system diffuse large B-Cell lymphoma (CNS-DLBCL) are aggressive brain tumors with overlapping MRI features, yet distinct treatment approaches. Non-invasive tools are needed to aid in differential diagnosis. Deep learning on T1 post-contrast and T2-weighted MRI sequences were used to differentiate GBM and CNS-DLBCL. A three-stage temporal study design was utilized. Model development was performed on 146 CNS-DLBCL and 146 age, sex, and MRI year matched GBM patients diagnosed at Mayo between 1998-2019. Models were tested on independent temporal test cohorts. Initial testing included 240 independent GBM diagnosed at Mayo between 1998-2019. The prospective test cohort included 37 CNS-DLBCL and 256 GBM diagnosed at Mayo after January 1, 2020, and 36 CNS-DLBCL diagnosed at an external institution. Of the patients diagnosed at Mayo, 47% had MRIs generated from non-Mayo institutions. Two different model approaches were compared: (i) ensemble approach using AUC and cross validation for model selection, and (ii) loss approach minimizing cross entropy loss and cross validation to evaluate prediction performance. AUC on the prospective test cohort was 0.84 (95% CI: 0.78-0.90) and 0.83 (95% CI: 0.77-0.88) for the ensemble and loss approach, respectively. Stability of ensemble prediction improved with increasing number of models. Stratified AUC analysis demonstrated consistent performance across sex and age. We utilized a robust temporal study design and applied two different analytical approaches to develop a classification model. The findings confirm the feasibility of using MRI-based deep learning models to differentiate GBM from CNS-DLBCL.
Details
- Title: Subtitle
- MRI Deep Learning for Differentiating Glioblastoma, IDH-Wildtype from Central Nervous System Diffuse Large B-cell Lymphoma
- Creators
- Mana Moassefi - Mayo ClinicPaul A Decker - Mayo ClinicGian Marco Conte - Mayo Clinic in ArizonaMatthew L Kosel - Mayo ClinicAnnette M Molinaro - University of California, San FranciscoMoritz A Niederschweiberer - Mayo ClinicYalda Nikanpour - Mayo ClinicMichael W Ruff - Mayo ClinicTerry C Burns - Mayo ClinicUmar Farooq - University of IowaColin Derdeyn - University of Iowa Hospitals and ClinicsThomas M Habermann - Mayo ClinicJames R Cerhan - Mayo ClinicJeremy D W Greenlee - University of IowaMatthew A Howard - University of IowaSusan L Slager - Mayo ClinicRachael A Vaubel - Mayo ClinicRobert B Jenkins - Mayo ClinicDaniel H Lachance - Mayo ClinicBradley J Erickson - Mayo ClinicW Oliver Tobin - Mayo ClinicJeanette E Eckel-Passow - Mayo Clinic
- Resource Type
- Journal article
- Publication Details
- Cancer research communications
- DOI
- 10.1158/2767-9764.CRC-25-0710
- PMID
- 42081255
- ISSN
- 2767-9764
- eISSN
- 2767-9764
- Publisher
- American Association for Cancer Research
- Language
- English
- Electronic publication date
- 05/04/2026
- Academic Unit
- Neurology; Hematology, Oncology, and Blood & Marrow Transplantation; Stead Family Department of Pediatrics; Epidemiology; Iowa Neuroscience Institute; Neurosurgery; Otolaryngology; Internal Medicine
- Record Identifier
- 9985161449602771
Metrics
1 Record Views